首页> Gynecologic oncology> Peritoneal cancer risk after risk reducing salpingo-oophorectomy, impact of mutational status and STIC lesions.

Peritoneal cancer risk after risk reducing salpingo-oophorectomy, impact of mutational status and STIC lesions.

导出 LinkOut

翻译打印收藏纠错

第一作者： Claire,Saule

第一单位： Department of Genetics, Institut Curie, Paris, France. Electronic address: claire.saule@curie.fr.

作者： Claire,Saule ^[1] ; Enora,Laas ^[2] ; Nina,Weber ^[3] ; Guillaume,Bataillon ^[3] ; Veronique,Becette ^[4] ; Julie,Perlbarg-Samson ^[5] ; Nicolas,Pouget ^[6] ; Anne,Donnadieu ^[7] ; Aullène,Toussaint ^[6] ; Chrystelle,Colas ^[8] ; Anne,Vincent-Salomon ^[3] ; Sophie,Frank ^[9] ; Eric,Pasmant ^[10] ; Dominique,Stoppa-Lyonnet ^[9] ; Virginie,Fourchotte ^[2] ; Emmanuelle,Mouret-Fourme ^[9]

作者单位： Department of Genetics, Institut Curie, Paris, France. Electronic address: claire.saule@curie.fr. ^[1] Department of Surgery, Institut Curie, Paris, France. ^[2] Department of Pathology, Institut Curie, Paris, France. ^[3] Department of Pathology, Institut Curie, Saint-Cloud, France. ^[4] Department of PMSI, Institut Curie, Saint-Cloud, France. ^[5] Department of Surgery, Institut Curie, Saint-Cloud, France. ^[6] Department of Medical Oncology, Institut Curie, Saint-Cloud, France. ^[7] Department of Genetics, Institut Curie, Paris, France; Institut Curie, PSL, Research University, INSERM, U1339, F-75005 Paris, France. ^[8] Department of Genetics, Institut Curie, Paris, France. ^[9] Department of Genetics, Institut Curie, Paris, France; Institut Cochin, Inserm U1016, CNRS UMR8104, Université Paris Cité, CARPEM, Paris, France. ^[10]

关键词 BRCA1 and BRCA2 genes Breast and ovarian predisposition Ovarian cancer risk Peritoneal cancer risk RRSO STIC